Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a blood clotting or bleeding disorder (known medically as a thrombosis and hemostasis disease)
Who may not be able to join:
- People whose long-term follow-up information is not available for any reason, or who have a serious additional illness that prevents ongoing contact with the trial team
- People with alcohol or drug addiction, or a mental illness, that affects their ability to follow the study requirements
- People who have any other condition that, in the opinion of the trial investigator, could put them at risk or affect their ability to participate safely
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiao-Hui Zhang, MD, Peking University Institute of Hematology, Peking University People's Hospital
Phone: 086-01088326002
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Prognosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.